Phenominer Database Results (23 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Average Type Value Units SEM SD Method Method Duration Post Insult Time Value Method Notes Clinical Measurement Notes Record ID Study ID
F344/Jcl percentage of study population developing ventral prostate tumorous lesions during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 8 50.0 % ex vivo light microscopy 0 0 65824 341
F344/Jcl ventral prostate gland wet weight control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. ventral prostate mass male 900 days 8 0.27 g post excision weight measurement 0.0 0 65827 341
F344/Jcl percentage of study population developing leukemia during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. leukocyte integrity trait male 900 days 8 25.0 % ex vivo light microscopy 0 0 leukemia incidence 66142 341
F344/Jcl percentage of study population developing subcutaneous tumors during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. hypodermis integrity trait male 900 days 8 38.0 % necropsy 0.0 0 CMO:0003387 percentage of study population developing subcutaneous tumors during a period of time 106886 341
F344/Jcl area of ventral prostate occupied by tumorous lesions to total ventral prostate area ratio control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 8 0.25 % ex vivo light microscopy with digital image analysis 0.0 0 67947 341
F344/Jcl percentage of study population developing testis tumors during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. testis integrity trait male 900 days 8 100.0 % ex vivo light microscopy 0.0 0 testis tumor incidence 65841 341
F344/Jcl liver wet weight control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. liver mass male 900 days 8 12.7 g post excision weight measurement 0 method not specified, assumed to be digital scale 13304 341
F344/Jcl number of ventral prostate tumorous lesions with solid structure control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 8 0.4 null 0.25 0.7 ex vivo light microscopy 0.0 0 109888 341
F344/Jcl area of ventral prostate occupied by tumorous lesions with solid structure to total ventral prostate area ratio control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 8 0.07 % 0.05 0.15 ex vivo light microscopy with digital image analysis 0.0 0 109892 341
F344/Jcl prostate gland wet weight control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate mass male 900 days 8 0.92 g post excision weight measurement 0.0 0 65832 341
F344/Jcl both testes wet weight control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. testis mass male 900 days 8 6.62 g post excision weight measurement 0 0 65821 341
F344/Jcl spleen wet weight control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. spleen mass male 900 days 8 null 2.34 g post excision weight measurement 0 method not specified, assumed to be digital scale 13306 341
F344/Jcl percentage of study population developing ventral prostate tumorous lesions with a solid structure during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 8 25.0 % ex vivo light microscopy 0.0 0 109886 341
F344/Jcl percentage of study population developing unilateral renal agenesis during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. kidney integrity trait male 900 days 8 0.0 % necropsy 0.0 0 106884 341
F344/Jcl area of individual ventral prostate tumorous lesion with round, irregular size nuclei control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 8 0.22 mm2 0.11 0.3 ex vivo light microscopy with digital image analysis 0.0 0 109962 341
F344/Jcl area of ventral prostate occupied by tumorous lesions with round, irregular size nuclei to total ventral prostate area ratio control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 8 0.24 % 0.12 0.33 ex vivo light microscopy with digital image analysis 0.0 0 109964 341
F344/Jcl area of individual prostate tumorous lesion control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 8 0.22 mm2 ex vivo light microscopy with digital image analysis 0 0 65839 341
F344/Jcl body weight control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. body mass male 900 days 8 null 350.7 g body weighing method 0 method not specified, assumed to be digital scale 13302 341
F344/Jcl percentage of study population developing bilateral testis tumors during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. testis integrity trait male 900 days 8 88.0 % ex vivo light microscopy 0.0 0 necropsy bilateral testis tumor incidence 67949 341
F344/Jcl area of individual ventral prostate tumorous lesion with a solid structure control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 8 0.06 mm2 0.05 0.14 ex vivo light microscopy with digital image analysis 0.0 0 109890 341
F344/Jcl percentage of study population developing ventral prostate tumorous lesions with round, irregular size nuclei during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 8 38.0 % ex vivo light microscopy 0.0 0 109958 341
F344/Jcl number of ventral prostate tumorous lesions with round, irregular size nuclei control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 8 1.3 null 0.64 1.8 ex vivo light microscopy 0.0 0 109960 341
F344/Jcl prostate tumorous lesion number control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 8 1.5 null ex vivo light microscopy 0 0 65823 341